Shoulder Innovations reported Q4 net revenue of USD 14.42 million, up 65% year over year on higher implant systems sold and new customers. Q4 gross margin was 76.7%, down 1 percentage point from a year earlier. Q4 operating loss widened to USD 8.5 million as selling, general and administrative expense rose 79% to USD 16.34 million, partly due to higher commercial headcount and legal costs tied to litigation. For FY2025, net revenue rose 50% to USD 47.32 million, while net loss was USD 40.36 million. The company forecast FY2026 net revenue of USD 62 million to USD 65 million, and CEO Rob Ball said momentum remains strong heading into 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shoulder Innovations Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202603101605PR_NEWS_USPR_____FL06883) on March 10, 2026, and is solely responsible for the information contained therein.
Comments